English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduJust days into his second term, President Donald Trump is working quickly to implement his agenda. DePaul University experts are available to discuss key topics surrounding Trump’s first 100 days, including foreign policy, immigration, climate policy and health care.
Tag: WHO
FAU Researchers Confront New U.S. and Global Challenges in Vaccinations of Adults
Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
Global Health Expert to Discuss Africa’s Mpox Response and Vaccine Equity
Professor Helen Rees Chairs the WHO African Regional Technical Advisory Group on Immunization and co-chairs National Department Mpox Incident Management Team overseeing South Africa’s Mpox response. She is a member of the African CDC Emergency Consultative Group that declared MPOX…
Governments Fail to Reach Consensus on Pandemic Prevention Agreement
Member states of the World Health Organization (WHO) did not reach consensus on a new agreement or treaty on pandemic prevention, preparedness, and response.
Tuberculosis Therapy: Smallest Particles Will Deliver the Drug to the Lungs in Future
Therapy of the dangerous infectious disease of tuberculosis faces the challenge of pathogens frequently being resistant to several common antibiotics. Researchers of Karlsruhe Institute of Technology (KIT) have now developed nanoparticles to deliver new antibiotics directly to the lungs in future. Surfactants ensure that the highly fat-soluble antibiotics disperse very finely in water and can be inhaled. First tests at the Research Center Borstel, Leibniz Lung Center, reveal a high effectiveness and good compatibility of the nanocarriers of antibiotics. The researchers report in ACS Nano. (DOI: 10.1021/acsnano.3c01664)
What You Should Know About Mpox
Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.
New Low-cost Device Rapidly, Accurately Detects Hepatitis C Infection
The entire virus detection process is executed inside a uniquely designed, portable, inexpensive, disposable, and self-driven microfluidic chip. The fully automated sample-in–answer-out molecular diagnostic set-up rapidly detects Hepatitis C virus in about 45 minutes and uses relatively inexpensive and reusable equipment costing about $50 for sample processing and disease detection. The disposable microfluidic chip also offers shorter times for a reliable diagnosis and costs about $2.
Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders: What’s next?
The World Health Organization’s 75th World Health Assembly convenes May 22, with implications for epilepsy and other neurological disorders. Join us for a webinar discussing the member states’ vote on the Intersectoral Global Action Plan.
Genetics/biotech expert offers comments & availability on IVG (in vitro gametogenesis) major breakthrough
A groundbreaking study demonstrating the most advanced form of in vitro gametogenesis (making eggs from stem cells, IVG) was published Thursday in Science. See STAT’s coverage of the study. Regarding the study and breakthrough, Dr. Kevin Doxzen offers the below comments…
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation
Front Line COVID-19 Critical Care Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization (WHO)
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19
Global Respiratory Groups Join WHO, Calling On World Leaders to Act On the Commitments Made to End TB
In support of World TB Day, March 24, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, joins the World Health Organization campaign urging governments to act on the commitments made to end TB.
GLOBAL POLIOVIRUS RISK MANAGEMENT AND MODELING
Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988–2018, according to the World Health Organization (WHO). More than 30 years later, stubborn outbreaks of wild poliovirus still occur in Afghanistan and Pakistan, where cases have been increasing since 2018. The global eradication of polio continues to be an elusive goal.
Remdesivir for COVID-19: FDA Approved but Still Unproven
In a review of evidence from the most reliable data from randomized trials to find likely small-to-moderate effects of remdesivir, researchers say that totality of evidence compiled before the WHO trial results justifies compassionate use of remdesivir for severely ill patients. A smaller trial in China showed significantly decreased mean recovery time but no suggestion of a mortality benefit. ACTT-1 found the same mean recovery time and a suggestion of a mortality benefit that did not achieve statistical significance.
The US’ Withdrawal from the WHO Will Increase Death Rates and Threatens Global Security
President Trump’s decision to withdraw the US and its financial support from the World Health Organization is grossly irresponsible at any time but particularly so during a pandemic.
WashU Expert: America gains nothing by leaving WHO
President Donald Trump’s recent announcement to suspend U.S. funding to, and withdraw from, the World Health Organization is “counter to our interests in addressing our needs to save the lives and further the health of Americans, as well as an abandonment of America’s position as a global leader,” says the director of Washington University in St.
WashU Expert: WHO withdrawal may not be legal
President Donald Trump announced July 7 that the United States has officially begun to withdraw from the World Health Organization (WHO). Trump may or may not have the authority to do so, says an expert on health law at Washington University in St. Louis.“It’s not clear that the president can unilaterally withdraw the United States from membership in the WHO,” said Rachel Sachs, associate professor of law and a renowned expert on health policy and drug law.
Move to Withdraw U.S. from WHO During Global COVID-19 Pandemic Very Concerning;
The American Thoracic Society (ATS) is deeply concerned by the Trump Administration’s action today to withdraw the United States from the World Health Organization (WHO).
ARN Board Member Maureen Musto Selected for Development Group Working on the World Health Organization “Rehabilitation 2030” Initiative
The Association of Rehabilitation Nurses is proud to announce that ARN Board Member Maureen Musto, MS RN APRN-CNS ACNS-BC CRRN, has been selected to serve on the Development Group for Traumatic Brain Injury and Parkinson’s Disease working on development of the World Health Organization (WHO) Rehabilitation Programme’s Package of Interventions for Rehabilitation (PRI).
OADN Applauds State Of The World’s Nursing 2020: Investing In Education, Jobs And Leadership Report
OADN applauds the recommendations of the World Health Organization’s State of the World’s Nursing 2020: Investing in Education, Jobs and Leadership report.
How can we be more sure social media posts about coronavirus are accurate?
As COVID-19 has increasingly isolated us from each other, we’re relying more and more on social media for a sense of connection and as a source of information about the virus and it’s spread. But how can we be more confident that what we’re seeing is accurate?
Biophysical Society Statement on COVID-19
.ROCKVILLE, MD – As concern continues to grow concerning the novel coronavirus, COVID-19, so does the opportunity for misinformation to spread as the public searches for reliable information on infection and means of protection.
Panicky Responses to the Coronavirus are Dangerous—Here’s Why
Fear of the virus may spread faster than the virus itself, a potential threat to health, liberty, trade, and the economy.
New Tool Monitors Real Time Mutations In Flu
A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.
As shadow of SARS haunts China, U.S. confirms first case of Coronavirus
CORNELL UNIVERSITY MEDIA RELATIONS OFFICEJan. 21, 2019 As shadow of SARS haunts China, U.S. confirms first case of Coronavirus Health officials in China are seeking to control the outbreak of a new type of coronavirus that they say can spread…
Why Experts Are Worried About a New Virus in China
The virus appears to be less dangerous than SARS, but there are still concerns of a wider outbreak in Asia.
The End of Antibiotics?
Less than a century after the discovery of antibiotics, the world is at risk of entering an era in which the life-saving drugs no longer work.
Injection drug use: not the same across Canada
A new study by researchers at the University of Montreal shows close to 172,000 Canadians injected drugs in 2016, up from 130,000 just five years earlier, but support varies.
Epilepsy is a threat to public health, says international report
Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.
Epilepsy is a threat to public health, says international report
Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.
Ageism reduced by education, intergenerational contact
ITHACA, N.Y. – Researchers at Cornell University have shown for the first time that it is possible to reduce ageist attitudes, prejudices and stereotypes through education and intergenerational contact. Ageism is the most socially acceptable prejudice on the planet, according…